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Abstract 
Patients with diabetes are a high-risk group for cognitive disorders, the exact pattern and the magnitude of this are still unclear. 
The research to identify the studies was performed in the databases Medline, Pubmed, ScienceDirect. Following the analysis of 
eligibility a number of 9 studies were included in the meta-analysis. Adults with diabetes showed lower performance than control 
subjects in all cognitive domains. Although the effect sizes of the diabetes on cognitive functions generally oscillate between low 
and moderate values they should still be considered because they can affect daily activities. 
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1. Introduction 
Several chronic diseases, such as diabetes, a series of cardiovascular diseases and high blood pressure, are 
considered to be factors of major risk for the decline of intellectual abilities (Attree et al., 2003). A multitude of 
studies reported negative impact of diabetes on cognitive abilities, the patients with diabetes mellitus presenting a 
high risk factor for the development of cognitive problems compared to healthy persons (Ebady et al., 2008; Kodl & 
Seaquist, 2008). Although a special attention was given in the related literature to the risk of cognitive disorders 
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among individuals with diabetes, the studies revealed mixed results. While some studies have suggested that 
diabetes is associated with a decreased performance on cognitive tests (Wu et al., 2003; Van Harten et al., 2007), 
others found no significant correlation between these conditions and cognitive disorder (Lindeman et al., 2001; 
Kumari et al., 2005). Overall, transversal studies have produced inconsistent results, often with a high degree of 
ambiguity; this may be attributed to discrepancies between the methods of measurement (Desrocher & Rovet, 2004). 
The relation between diabetes and cognitive functions is not yet clearly documented (Pasquier, 2010). We 
performed a meta-analysis of the relevant literature to determine the magnitude of cognitive dysfunctions in adults 
with diabetes compared to non-diabetic control subjects. We also propose to identify the role of the glycemic control 
and the diabetes duration in the impairment of cognitive processes. 
2. Method 
Selection of studies
The research to identify the studies on cognitive performances in patients with diabetes compared with non-
diabetic control subjects was performed in the databases Medline, Pubmed, ScienceDirect using the search phrases: 
cognitive functions, memory, attention, learning, information processing and intelligence. They were combined with 
terms diabetes, type 1 and type 2 diabetes. Abstracts (989) were examined to determine if the studies meet the 
following inclusion criteria: 1) published or available in English 2) subjects aged between 18 and 65 (mean) 3) had a 
defined control group (healthy subjects), 4) studies provide sufficient information on the characteristics of 
participants, methodological features and the conceptualization of factors, 5) evaluated cognitive performance using 
standard neuropsychological tests at normal blood glucose values, 6) test results were presented for experimental 
and control groups. A number of 9 studies were included in the meta-analysis. 
Encoding the studies
Encoding general characteristics of the studies was direct, based on information found in the study (Table 1).   
Table 1. Characteristics of the studies 
Author / year 
Study 
type 
n
(diabetes/ 
control) 
Age
(diabetes/ 
control) 
Type of 
diabetes 
Diabetes 
duration 
  (Years) 
Glycemic 
control 
(HbA1c) 
Cognitive domains 
measured 
1 Ryan et al. (1993) CS 142/100 
33.5±5,6/ 
34.1±6.7 
type 1 24.8±6.1 10.6±1.8 
VeI, A,L,PV,APM, 
FE 
2 Ryan et al. (2000) CS 50/50 
50.8±7.7/ 
50.5±7.4 
type 2 8.1±5.9 10.2±2.4 
VeI,ViI,VeD, ViD, 
GM,A, PV,APM,FE 
3 Cosway et al. (2001) CS 38/38 
57.7(10.3)/ 
55.9(11.2) 
type 2 6.0(3.0,11.3) 7.6(6.6,9.5) 
IQ, VeI,ViI, VeD, ViD, 
GM, L, 
4
Asimakopoulou et al. 
(2002)
CS 33/33 
62.40(9.62)/ 
62.40(9.62 
type 2 9(5.91) ND WM, Vei, VeD,A, FE 
5 Lobnig et al. (2005) CS 13/13 
41.3±1.3/ 
38.5±1.5 
type 1 27.7(14 -36) 
8.2±0.3 
WM, VeI, VeD, A, FE 
6 Gold et al. (2007) CS 23/23 
59.2±8.4/ 
59.9±8.6 
type 2 6.0±6.3 
6.9±0.8 WM, VeI, VeD, GM, A, 
FE 
7 Bruehl et al. (2007) CS 30/30 
59.16±8.58/ 
59.12±8,40 
type 2 7.43±7.26 7.5±1.45 
IQ, WM, VeI, VeD, 
GM, A, L, FE 
8 Weinger et al. (2008) CS 114/58 
32±4/ 
30±5 
type 1 20±4 7.8±1.4 
WM; VeI, 
VeD,A,L,PV,APM,FE 
9 Bruehl et al. (2009) CS 41/47 
59.05±8.38/ 
60.02±7.96 
type 2 7±6.4 7.88±1.83 IQ,VeI, VeD 
CS- cross sectional, ND- not defined, IQ- intelligence quotient, WM-Working memory,VeI-Verbal learning and immediate memory, ViI- Visual 
learning and immediate memory, VeD-Verbal delayed memory and learning, ViD- Visual delayed memory and learning, GM-Genereal learning 
and memory, A-Attention, L-Language, PV-Visual processing, APM-Psychomotor activity , FE- Executive functions
Cognitive functions measured in this meta-analysis were classified on the basis of the American Academy of 
Neurology (1996) and after the book of Lezak (2004) and other relevant classifications in the field (Strauss et al., 
2006; Groth-Marnat, 2009). In the studies various tests were used to evaluate similar aspects of cognition, or the 
same test was used to evaluate different areas, therefore we reclassified the tests used in the studies included in the 
meta-analysis according to the relevance of the classification (Table 2). 
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Table 2. Classification of cognitive functions and tests 
Cognitive domains Examples of tests 
1. Global cognitive function, IQ (WAIS, Raven ,WASI) 
2. Memory and learning (WMS-R, WMS III; RAVLT, CVLT) 
3. Working memory 
Digit span (WMS R, WAIS) or other alternatives (Guild Memory Scale, Nuernberger Alters 
Inventar); Letter Number Sequencing scaled (WMS III) 
Short-term 
memory 
4 . Immediate verbal 
memory 
Logical memory immediate recall  subscale (WMS-R); Verbal paired associate immediate recall  
(WMS-R, WMS, WMS III) or other alternatives (Verbal paired associate learning test, Guild memory 
test, Nuernberger Alters Inventar; CVLT - short delay recall) 
5. Immediate visual 
memory 
Visual  paired associate immediate recall subscale (WMS-R, WMS, WMS III); or other alternatives 
(Symbol digit  paired associeta learning test) 
Long-term 
memory 
6. Delayed verbal 
memory 
Logical memory delayed  recall subscale (WMS-R ); Verbal paired associate delayed (WMS-R, 
WMS, WMS III) or other alternatives (Verbal paired associate learning test , Guild memory test, 
Nuernberger Alters Inventar, CVLT -long delay recall) 
7. Delayed visual 
memory 
Visual  paired associate  delayed recall (WMS-R, WMS, WMS III) or other alternatives (Symbol digit  
paired associeta learning test) 
8. Attention Digit symbol (WAIS, WMS); Trail Making  A test; Digit vigilance test  
9. Language 
Verbal Fluency Test;Word fluency -  Controlled Oral Word Association  (FAS) Test; Vocabular 
subscales of WASI, WAIS-R 
10. Procesare  vizuală/ vizuospatială Block design (WAIS, WASI); Object assembly subtest (WAIS R) 
11. Psychomotor activity Grooved Pegboard; Embedded figures test 
12. Executive functions (STROOP test; Trail Making B test; Category test; Wisconsin Card Sorting Test; D-KEFS 
Tests measuring the same cognitive domains were taken together in the analysis. Cognitive functions that could 
not be classified according to these areas were not included in the meta-analysis. 
Statistical analysis
We computed the effect size (Cohen’s d) according to the basic standard literature (Hunter & Schmidt, 2004). 
The results were evaluated on the same basis, following the effect size measures described by Cohen (0.2-0.5 = 
small, 0.5-0.8 = medium, 0.8< = large effect size) (Cohen, 1988). Data analysis was performed by the Meta-
Analysis Calculator (http://www.lyonsmorris.com), complemented with custom written formulas. The first 
computations resulted in 89 effect sizes for the different cognitive domains all together. Since the studies included in 
the meta-analysis used several psychometric measures for the same domain, after closing up these, 57 effect sizes 
remained  to  work  with.  The  direction  of  the  effect  size  is  shown  with  a  +  or  –  sign.  The  –  sign  shows  poorer  
performance of diabetic patients in the cognitive tasks as compared with the control group. To compensate for the 
possible errors due to different sample sizes we computed a corrected effect size measure (D).  
3. Results  
Influence of diabetes on cognitive functions 
Adults with diabetes showed lower performance than control subjects in all cognitive domains (Table 3). The 
effect sizes have the highest value on immediate verbal memory (D= -0.71), on delayed verbal memory (D= 0, 71), 
on psychomotor activity (D= -0.71) and overall intellectual abilities (D= -0.68). The data show little effect on 
general memory (D= -0.37), visual and visuo-special processing (D= -0.35), executive functions (D= -0.28), for 
attention / focus of (D= -0.42) and language / verbal skills (D= -0.42). 
Table 3. The effect size (d) and corrected effect size (D) on the analyzed categories 
Nr Categories Study 
number 
Number of 
sizes effects 
on class 
Total 
number of 
subjects 
Effect size 
(d) 
Corrected 
effect size 
(D)
VarD 95% confidence 
interval 
1 Global cognitive function , IQ 3 3 224 -0.68 -0.68 0.17 [-1.15, -0.21] 
2 Working memory 5 9 370 -0.08 -0.13 0.11 [-0.42, 0.17] 
3 Immediate verbal memory 9 16 876 -0.85 -0.71 1.12 [ -1.40, -0.02] 
4 Immediate visual memory 2 2 176 -0.11 -0.11 0.01 [-0.13, -0.10] 
5 Delayed verbal memory 8 15 634 -0.75 -0.71 1.10 [ -1.44, 0.01] 
6 Delayed visual memory 2 2 176 -0.08 -0.007 0.06 [ -0.34,  0.32] 
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7 Memory and learning 4 5 282 -0.50 -0.37 0.21 [-0.82,  0.07] 
8 Attention 7 10 712 -0.43 -0.42 0.03 [ -0.55, -0.31] 
9 Language 4 4 550 -0.41 -0.42 0.02 [-0.55, -0.29] 
10 Visual processing 3 4 514 -0.33 -0.35 0.01 [ -0.47, -0.23] 
11 Psychomotor activity  3 4 514 -0.71 -0.71 0.03 [ -0.93, -0.51] 
12 Executive functions 7 12 712 -0.38 -0.28 0.03 [-0.41, -0.16] 
On working memory category (D= -0.13), immediate visual memory (D= -0.11) and delayed visual memory (D= 
-0.007), the data indicate a very small effect, as well as inconsistent, the diabetes group having almost the same 
performances to these samples as the healthy control group.  
The role of the diabetes duration and glycemic control in the impairing of cognitive processes 
We calculated the predictive effect of the relation between glycemic control and cognitive functions, then the 
relation between diabetes duration and cognitive functions. The statistical sample between the 12 selected areas only 
in the case of psychomotor activity supports the hypothesis that glycemic control would be predictive on cognitive 
functions (R2= 0.99, p= .02), the results being insignificant for other areas. The statistical evidence does not support 
the hypothesis that the diabetes duration has any effect on cognitive functions, the results being insignificant for any 
of the 12 cognitive domains. 
4. Conclusion 
Following the analysis of eligibility a number of 9 studies were included in the meta-analysis. The selection 
criteria was very strict,  including only  people aged between 18 and 65 years old; and evaluated cognitive 
performance using standard neuropsychological tests on normal blood glucose level. Cognitive deficits appear to be 
more pronounced in individuals who are more than 65 years of age, so we want to avoid the damaging effect of age 
on cognitive performance. But this is one of the strengths of the study too, because we wanted to exclude all other 
variables, which may have influenced cognition. 
We proposed to determine the magnitude of cognitive dysfunctions in adults with diabetes. The present study 
supports the hypothesis that there is an association between diabetes and cognitive dysfunctions. Although the effect 
sizes of the diabetes on cognitive functions are low and moderate, it still should be considered important, because 
the cognitive dysfunctions can affect daily activities. In our study, we analyzed the effect of metabolic control and 
the diabetes duration on cognitive performance. We found that the diabetes duration was not predictive on the 
cognitive dysfunctions, and the metabolic control was predictive only on the psychomotor activity. The reason of 
this association is not absolutely clear, this assumption needs further research. It should be investigated other effects 
of disease variables as complications, comorbidities or other factors. The complications, however, cannot occur 
without a long-time inadequate glycemic control. 
As any other meta-analysis this study has also its limitations. One is the relatively large number of studies which 
had to be excluded due the lack of sufficient data to calculate the effect size or meet the selection criteria. The main 
open questions that remain are the role of the different disease variables, such as the development of micro vascular 
complications, and the possible influence of comorbid conditions. The results of the current study support the 
hypothesis that there is a relationship between cognitive dysfunction and diabetes. This study was a preliminary 
analysis and for the future we want to analyze separately the two types of diabetes. 
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